| Bioactivity | Ibuzatrelvir (PF-07817883) is an antiviral agent, targeting to SARS-CoV-2 3CL protease. Ibuzatrelvir can be used to inhibit COVID-19[1]. |
| Target | SARS-CoV-2 3CL protease, COVID-19 |
| Name | Ibuzatrelvir |
| CAS | 2755812-39-4 |
| Formula | C21H30F3N5O5 |
| Molar Mass | 489.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Owen, et al. Preparation of peptidomimetic nitriles as SARS-CoV-2 3CL protease inhibitors and methods for the treatment of COVID-19. World Intellectual Property Organization, WO2021250648 A1. 2021-12-16. |
Ibuzatrelvir
CAS: 2755812-39-4 F: C21H30F3N5O5 W: 489.49
Ibuzatrelvir (PF-07817883) is an antiviral agent, targeting to SARS-CoV-2 3CL protease. Ibuzatrelvir can be used to inhi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.